... Once-Weekly Insulin Efsitora Alfa Versus Once-Daily Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3): A Phase 3, Randomised, Non-Inferiority Trial — The Lancet Once-Weekly Insulin Efsitora Alfa Versus Once-Daily Insulin Glargine U100 in Adults With Type 2 Diabetes Treated With Basal and Prandial Insulin ...
Once-Weekly Efsitora Insulin Matches Daily Injections for Type 2 Diabetes in Studies
... Once-Weekly Insulin Efsitora Alfa Versus Once-Daily Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3): A Phase 3, Randomised, Non-Inferiority Trial — The Lancet Once-Weekly Insulin Efsitora Alfa Versus Once-Daily Insulin Glargine U100 in Adults With Type 2 Diabetes Treated With Basal and Prandial Insulin ...